Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients

Journal of NeuroVirology

Volumn 4, Issue 1, 1998, Pages 120-132

  Cinque, Paola ^a   Cleator, Graham M ^b   Weber, Thomas ^c   Monteyne, Philippe ^d   Sindic, Christian ^d   Gerna, Guiseppe ^e   Van Loon, Anton M ^f   Klapper, Paul E ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Marien Krankenhaus Hamburg   (Germany)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f Academic Hospital Utrecht   (Netherlands)

Author keywords

CMV; Encephalitis; Foscarnet; Ganciclovir; Nervous system; PCR

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN DETECTION; ARTICLE; BRAIN INJURY; CEREBROSPINAL FLUID ANALYSIS; CYTOMEGALIC INCLUSION BODY DISEASE; DRUG EFFICACY; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; POLYRADICULITIS; PRIORITY JOURNAL; VIRUS ISOLATION;

EID: 0031892663     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809113490     Document Type: Article

References (115)

1. Achim CL, Nagra RM, Wang R, Nelson JA, Wiley CA (1994). Detection of cytomegalovirus in cerebrospinal fluid autopsy specimens from AIDS patients. J Infect Dis 169: 623-627.
2. Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV (1986). The neuropathology of AIDS. UCLA experience and review. Am J Pathol 124: 537-558.
3. Anderson KP, Fox MC, Brown-Driver V, Martin MJ, Azad RF (1996). Inhibition of human cytomegalovirus immediate early gene expression by an antisense oligonucleotide complementary to immediate-early RNA. Antimicrob Agents Chemother 40: 2004-2011.
4. Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Oowderly WG, Storch GA (1995). Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 172: 527-531.
5. Arribas JR, Storch GA, Clifford DB, Tselis AC (1996). Cvtomegalovirus encephalitis. Ann Intern Medicine 125: 577-587.
6. Baldanti F, Silini E, Sarasini A, Talarico CL, Stanat SC, Biron KK, Furione M, Bono F, Palu G, Gerna G (1995). A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 69: 796-800.
7. Baldanti F, Underwood MR, Stanat SC, Biron KK, Chou S, Sarasini A, Silini E, Gerna G (1996). Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotranspherase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol 170: 1390-1395.
8. Berger DS, Bucher G, Nowak JA, Gomatos PJ (1996). Acute primary immunodeficiency virus type 1 infection in a patients with concomitant cytomegalovirus encephalitis. Clin Infect Dis 23: 66-70.
9. Berman SM, Kim RC (1994). The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. Am J Med 96: 415-419.
10. Blanshard C, Benhamou Y, Dohin E, Lernestedt J-O, Gazzard BG, Katlama C (1995). Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir. J Infect Dis 172: 622-628.
11. Boivin G, Chou S, Quirk MR, Erice A, Jordan MC (1996). Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal diseminated CMV disease. J Infect Dis 173: 523-528.
12. Bowen EF, Griffiths PD, Davey CC, Emery VC, Johnson MA (1996). Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 10: 1515-1520.
13. Brewster ME, Raghavan K, Pop E, Bodor N (1994). Enhanced delivery of ganciclovir to the brain through the use of redox targeting. Antimicrob Agents Chemother 38: 817-823.
14. Brown F, Arum T, Francis G, Patel M, Malcolm S (1997). Ganciclovir prodrug (RS-79070) - Multiple dose, doseranging study with effect of food. Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, USA, Abstract LB 19.
15. Buffet R, Agut H, Chieze F, Katlama C, Bolgert F, Devillechabrolle A, Diquet B, Schuller E, Pierrot-Deseilligny C, Gentilini M et al. (1991). Virological markers in the cerebrospinal fluid from HIV-1 - infected individuals. AIDS 5: 1419-1424.
16. Chiodi F, Norkrans G, Hagberg L, Sonnerborg A, Gaines H, Froland S, Fenyo EM, Norrby E, Vandvik B (1988). Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J Neurol Sci 87: 37-48.
17. Chou S, Erice A, Colin Jordan MC, Vercellotti GM, Michels KR, Talarico CL, Stanat SC, Biron KK (1995). Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 171: 576-583.
18. Cinque P, Vago L, Brytting M, Castagna A, Accordini A, Sundqvist VA, Zanchetta N, Monforte AD, Wahren B, Lazzarin A et al. (1992). Cytomegalovirus infection ofthe central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 166: 1408-1411.
19. Cinque P, Baldanti F, Vago L, Terreni MR, Lillo F, Furione M. Castagna A, Monforte AD, Lazzarin A, Linde A (1995). Ganciclovir therapy for cyto-megalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J Infect Dis 171: 1603-1606.
20. Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fornara C, Racca S Castagna A, Monforte AD, Wahren B, Lazzarin A, Linde A (1996a). Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951-958.
21. Cinque P, Pisa E, Racca S, (1996b). Efficacy of different antiviral treatments in cytomegalvirus neurological complications: evaluation by quantitative PCR on cerebrospinal fluid. Third International Congress on Drug Therapy in HIV Infection, Birmingham, UK, Abstract OP3.3.
22. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A (1997). Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 11: 1-17.
23. Clifford DB, Arribas JR, Storch GA, Tourtellotte W, Wippold FJ (1996). Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neurovirol 2: 397-403.
24. Clifford DB, Buller RS, Mohammed S, Robison L, Storch GA (1993). Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology 43: 75-79.
25. Cohen BA, McArthur JC, Grohman S, Patterson B, Glass JD (1993). Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology 43: 493-499.
26. Cohen BA (1996). Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology 46: 444-450.
27. Crumpacker CS (1996). Ganciclovir. N Engl J Med 335: 721-729.
28. Darnell RB (1993). The polymerase chain reaction: application to nervous system disease. Ann Neurol 34: 513-523.
29. de Gans J, Tiessens G, Portegies P, Tutuarima JA, Troost D (1990). Predominance of polymorphonuclear leukocytes in cerebrospinal fluid of AIDS patients with. cytomegalovirus polyradiculomyelitis. J Acquir Immune Defic Syndr 3: 1155-1158.
30. De Wit S, Snoeck R, Rossi C (1996). Treatment of progressive multifocal leukoencephalopathy with cidofovir in an AIDS patient. Third International Congress on Drug Therapy in HIV Infection, Birmingham, UK, Abstract P106.
31. Decker CF, Tarver JH, Murray DF, Martin GJ (1994). Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clin Infect Dis 19: 548-549.
32. Dieterich DT, Poles MA, Lew EA, Mendez PE, Murphy R, Addessi A, Holbro JT, Naughton K, Friedberg DN (1993). Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J Infect Dis 167: 1184-1188.
33. Dix RD, Bredesen DE, Erlich KS, Mills J (1985). Recovery of herpesviruses from cerebrospinal fluid of immunodeficient homosexual men. Ann Neurol 18: 611-614.
34. Domingo P, Puig M, Iranzo A, Lopez-Contreras J, Ris J (1994). Polyradiculopathy due to cytomegalovirus infection: report of a case in which an AIDS patient responded to foscarnet. J Infect Dis 18: 1019-1020.
35. Drew WL, Miner R, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Gordon SM, Owen WF Jr, Matthews TR, Buhles WC (1991). Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 163: 716-719.
36. Drew L, Miner R, Garvey J (1995a). Documentation of in vivo anti-CMV activity in the cerebrospinal fluid (CSF) by bDNA assay. The Second National Conference on Human Retroviruses and Related Infections. Washington, DC, United States of America.
37. Drew WL, Ives D, Lalezari JP, Crumpacker C, Follansbee SE, Spector SA, Benson CA, Friedberg DN, Hubbard L, Stempien MJ (1995b). for the Syntex Cooperative Oral Ganciclovir Study Group. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med 333: 615-620.
38. Drew WL, Lalezari J, Jordan C (1997). In vivo anticytomegalovirus activity and safety of oral lobucavir in HIV infected patients. Sixth International Cytomegalovirus Workshop. Orange Beach, Alabama, USA, Abstract 17.
39. Ebright JR, Crane LR (1991). Ganciclovir-resistant cytomegalovirs. AIDS 5: 604.
40. Enting R, De Gans J, Reiss P, Jansen C, Portegies P (1992). Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS. Lancet 340: 559-560.
41. Fiala M, Cone LA, Cohen N, Patel D, Williams K, Casareale D, Shapshak P, Tourtelotte W (1988). Responses of neurological complications of AIDS to 3′-azido-3′-deoxythimidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. I. Clinical features. Rev Infect Dis 10: 250-256.
42. Field AK, Tuomari AV, Mcgeever-Rubin B, Terry BJ, Mazina KE, Haffey ML, Hagen ME (1990). (±)-(1 a,2b,3a)-9-[2,3-bis(hydroxymethyl)-cyclobutyl]guanine-[(±)-BHCG or SQ33054]: a potent and selective inhibitor of herpes viruses. Antivir Res 13: 41-52.
43. Fillet AM, Katlama C, Visse B, Camilleri S, Rogeaux O, Huraux JM (1993). Human CMV infection of the CNS: concordance between PCR detection in CSF and pathological examination. AIDS 7: 1016-1017.
44. Fletcher C, Sawchuck R, Chinnok B, de Miranda P, Balfour H Jr (1986). Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther 40: 281-286.
45. Fox DJ, Brink NS, Zuckermann MA, Neild P, Gazzard BG, Tedder RS, Miller RF (1995). Detection of herpesvirus DNA by nested PCR in CSF of HIV-infected persons with neurological disease: a prospective evaluation. J Infect Dis 172: 1087-1090.
46. Freitas VR, Fraser-Smith EB, Matthews TR (1989). Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antivir Res 12: 205-212.
47. Fuller GN, Jacobs JM, Guiloff RJ (1989). Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection. Lancet 2: 937-941.
48. Fuller GN (1992). Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr 5 (suppl 1): S33-36.
49. Fuller GN, Jacobs JM, Guiloff RJ (1993). Nature and incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg and Psychiatry 56: 372-381.
50. Gozlan J, Salord JM, Roullet E, Baudrimont M, Caburet F, Picard O, Meyohas MC, Duvivier C, Jacomet C, Petit J (1992). Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis 166: 1416-1421.
51. Gozlan J, El Amrami M, Baudrimont M, Costagliola D, Salord JM, Duvivier C, Picard O, Meyohas MC, Jacomet C, Schneider-Fauveau V (1994). A prospective evaluation of clinical criteria and polymerase chain reaction of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS 9: 253-260.
52. Grafe MR, Wiley CA (1989). Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann Neurol 25: 561-566.
53. Hengge UR, Brockmeyer NH, Malessa R, Ravens U, Goos M (1993). Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis. Antimicrob Agents Chemother 37: 1010-1014.
54. Holida MD. Trigg ME, Rumelhart NF, Lee NF, Kook H, Peters C (1995). Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy. AIDS 9: 531-532.
55. Holland NR, Power C, Mathews VP, Glass JD, Forman M, McArthur JC (1994). Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology 44: 507-514.
56. Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H, O'Donnell JJ, Walker JD, Korvick JA, van der Horst C (1994). Randomised phase I trial of two combination foscarnet/ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis (AIDS Clinical Trial Group Protocol 151). J Infect Dis 170: 189-193.
57. Jeantils V, Lemaitre MO, Robert J, Gaudouen Y, Krivitzky A, Delzant G (1986). Subacute polyneuropathy with encephalopathy in AIDS with human cytomegalovirus pathogenicity? Lancet 2: 1039.
58. Kalayjian RC, Cohen ML, Bonomo RA, Flanigan TP (1993). Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features. Medicine 72: 67-77.
59. Kim YS, Hollander H (1993). Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 17: 32-37.
60. Klein JL, Price DA, Fischer M, Coker RJ (1996). Cytomegalovirus infection: a possible cause of recurrent transient neurological dysfunction in advanced HIV infection. AIDS 10: 345-346.
61. Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A, Dickson DW (1991). Human immunodeficiency virus -1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 22: 700-710.
62. Lalezari JP, Kemper C, Stagg R, (1996). A randomized, controlled study of the safety and efficacy of intravenous cidofovir (CDV, HPMPC) for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. XI International Conference on AIDS. Vancouver, Canada. Abstract Th.B.304.
63. Laskin OL, Cederberg DM, Mills J, Eron LJ, Mildvan D, Spector S (1987). Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med 83: 201-207.
64. Lea AP, Bryson HM (1996). Cidofovir. Drugs 52: 225-230.
65. Lurain N, Thompson KD, Holmes EW, Read GS (1992). Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resstance to antiviral agents. J Virol 66: 7146-7152.
66. McCutchan JA (1995). Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 20: 747-754.
67. Miller RG, Storey JR, Greco CM (1990). Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 40: 569-574.
68. Miller RF, Lucas SB, Hall-Craggs MA, Brink NS, Scaravilli F, Chinn RJ, Kendall BE, Williams IG, Harrison MJ (1996). Comparison of magnetic resonance imaging with neuropathological findings in the diagnosis of HIV and CMV associated CNS disease in AIDS. J Neurol Neurosurg Psychiatry 62: 346-351.
69. Morgello S, Cho ES, Nielsen S, Devinsky O, Petito CK (1987). Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol 18: 289-97.
70. Musiani M, Zerbini M, Venturoli S, Gentilomi G, Borghi V, Pietrosemoli P, Pecorari M, La Place M (1994). Rapid diagnosis of cytomegalovirus encephalitis in patients with AIDS using in situ hybridisation. J Clin Pathol 47: 886-891.
71. Neyts J, Sobis H, Snoeck R, Vandeputte M, De Clercq E (1993). Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. Ear J Clin Microbiol Infect Dis 12: 269-279.
72. Oberg B (1989). Antiviral effect of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther 40: 213-285.
73. Palestine AG, Polis MA, De Smet MD (1991). A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 115: 665-673.
74. Peters M, Timm U, Schurmann D, Pohle HD, Ruf B (1992). Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. Clin Invest 70: 456-458.
75. Petito CK, Cho ES, Lemann W, Navia BA, Price RW (1986). Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 45: 635-646.
76. Pollard RB (1996). CMV retinitis: ganciclovir/monoclonal antibody. Antivir Res 29: 73-75.
77. Post MJ, Hensley GT, Moskowitz LB, Fischl M (1986). Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation. AJR Am J Roentgenol 146: 1229-1234.
78. Price T, Digioia R, Simon G (1992). Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 15: 606-608.
79. Raffi F, Taburet AM, Ghaleh B, Huart A, Singlas E (1993). Penetration of foscarnet into cerebrospinal fluid of AIDS patients. Antimicrob Agents Chemother 37: 1777-1780.
80. Revello MG, Percivalle E, Sarasini A, Baldanti F, Furione M, Gerna G (1994). Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J Infect Dis 170: 1275-1279.
81. Roullet E, Assuerus V, Gozlan J, Ropert A, Said G, Baudrimont M, el Amrani M, Jacomet C, Duvivier C, Gonzales-Canali G (1994). Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 44: 2174-2182.
82. Said G, Lacroix C, Chemouilli P, Goulon-Goeau C, Roullet E, Penaud D, de Broucker T, Meduri G, Vincent D, Torchet M (1991). Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 29: 139-146.
83. Salazar A, Podzamczer D, Rene R, Santin M, Perez JL, Ferrer I, Fernandez-Viladrich P, Gudiol F (1995). Cytomegalovirus ventriculoencephalitis in AIDS patients. Scand J Infect Dis 165-169.
84. Sarasini A, Baldanti F, Furione M, Percivalle E, Brerra R, Barbi M, Gerna G (1995). Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. J Med Virol 47: 237-244.
85. Schmidbauer M, Budka H, Ulrich W, Ambros P (1989). Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization. Acta Neuropathol 79: 286-293.
86. Schwarz TF, Loeschke K, Hanus I, Jager G, Feiden W, Stefani FH (1990). CMV encephalitis during ganciclovir therapy of CMV retinitis. Infection 18: 289-290.
87. Setinek U, Wondrusch E, Jellinger K, Steuer A, Drlicek M, Grisold W, Lintner F (1995). Cytomegalovirus infection of the brain in AIDS-a clinicopathological study. Acta Neuropathol (Berlin) 90: 511-515.
88. Shepp DH, Dandliker PS, de Miranda P, Burnette TC, Cederberg DM, Kirk LE, Meyers JD (1985). Activity of 9- [2 - hydroxy-1-(hydroxymethyl)ethoxymethil]guanine in the treatment of cytomegalovirus pneumoniae. Ann Intern Med 103: 368-373.
89. Shinkai M, Spector SA (1995). Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand J Infect Dis 27: 559-561.
90. Singh N, Anderegg KA, Yu VL (1993). Significance of hypoglycorrhachia in patients with AIDS and cytomegalovirus meningoencephalitis. Clin Infect Dis 17: 283-284.
91. Sjovall J, Bergdahl S, Movin G, Ogenstad S, Saarimaki M (1989). Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection. Antimicrob Agents Chemother 32: 1733-1734.
92. Smith IL, Shinkay M, Freeman WR, Spector SA (1996). Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterisation of sequential virus isolates. J Infect Dis 173: 1481-1484.
93. So YT, Olney RK (1994). Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 35: 53-58.
94. Spector SA, Merrill R, Wolf D, Dankner WM (1992). Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 30: 2359-2365.
95. Spector S, Weingeist T, Pollard RB, Dietrich DT, Samo T, Benson CA, Busch DF, Freeman WR, Montague P, Kaplan HJ (1993). A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis 168: 557-563.
96. Spector SA, McKinley GF, Lalezari JP, Samo T, Andruczk R, Follansbee S, Sparti PD, Havlir DV, Simpson G, Buhles W, Wong R, Stempien M for the Roche Cooperative Oral Ganciclovir Study Group (1996). Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 334: 1491-1497.
97. Stark E, Haas J, Schedel I (1993). Diagnosis of cytomegalovirus infections of the nervous system by immunocytochemical demonstration of infected cells in cerebrospinal fluid. Eur J Med 2: 223-226.
98. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group (1996): Combination foscarnet and ganciclovir therapy versus monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. Arch Ophtalmol 114: 23-33.
99. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK (1992). A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358: 162-164.
100. Talpos D, Tien RD, Hesselink JR (1991). Magnetic resonance imaging of AIDS-related polyradiculopathy. Neurology 41: 1522-1523.
101. Tatarowitcz WA, Lurain NS, Thompson KD (1992). A ganciclovir-resistant ganciclovir isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis 166: 904-907.
102. The Oral Ganciclovir European and Australian Cooperative Study Group (1995). Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus recurrence in patients with AIDS. AIDS 9: 471-477.
103. Tokumoto JIN, Hollander H (1993). Cytomegalovirus polyradiculoapthy caused by a ganciclovir-resistant strain. Clin Infect Dis 17: 854-856.
104. Tyler KL (1994). Polymerase chain reaction and the diagnosis of viral central nervous system diseases. Ann Neurol 6: 809-811.
105. Vago L, Sala E, Nebuloni M, Sala E, Cinque P, Bonetto S, Isella A, Ottoni L,Crociati A, Costanzi G (1996). Coinfection of the central nervous system (CNS) by cytomegalovirus and herpes simplex virus type 1 or 2 in AIDS patients: autopsy study on 82 cases by immunocytochemistry and polymerase chain reaction. Acta Neuropathol (Berlin) 92: 404-408.
106. Van der Meer JT, Drew WL, Bowden RE, Galasso GJ, Griffiths PD, Jabs DA, Katlama C, Spector SA, Whitley RJ (1996). Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antivir Res 32: 119-140.
107. Vinters HV, Kwok MK, Ho HW, Anders KH, Tomiyasu U, Wolfson WL, Robert F (1989). Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 112: 245
108. Vogel JU, Cinatl J, Lux A, Weber B, Driesel AJ, Doerr HW (1996). New PCR assay for rapid and quantitative detection of human cytomegalovirus in cerebrospinal fluid. J Clin Microbiof 34: 482-483.
109. Walot I, Miller BL, Chang L, Mehringer CM (1996). Neuroimaging findings in patients with AIDS. Clin Infect Dis 22: 906-919.
110. Wang LH, Peck R, Chan PQ, Youle M, Eaves J, Bye A (1997). A phase I tolerability and pharmacokinetic trial of 1263W94, a novel anti-HCMV agent, in HIV-infected volunteers. Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC. USA, Abstract 674.
111. Weber T, Beck R, Stark E, Gerhards K, Korn K, Haas J, Luer W, Jahn G (1994). Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients. J Neurol 241: 407-414.
112. Weber T, Frye S, Bodemer M, Otto M, Luke W (1996). Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J Neurovirol 2: 175
113. Wolf DG, Spector SA (1992). Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J Infect Dis 166: 1412-1415.
114. Wolf DG, Lee DJ, Spector SA (1995). Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 39: 2552-2554.
115. Zou RM, Ayres KR, Drach JC, Townsend LB (1996). Synthesis and antiviral evaluation of certain disubstituted benzimidazole robonucleosides. J Med Chem 39: 3477-3482.